We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Unspecified mental disorder
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The Wellbeing While Waiting study seeks to evaluate a new social prescribing pathway that has already been co-developed and is currently being implemented by the Social Prescribing Youth Network (SPYN) and Child and Adolescent Mental Health Services (CAMHSs) for children and young people (CYP) on waiting lists for treatment.
Social Prescribing is a mechanism of connecting patients to non-medical forms of support within the community such as arts and cultural programmes, social groups, nature interventions and volunteering schemes. Typically, a health or social care professional refers a patient to a Link Worker (LW) or social prescriber, who works with the patient to identify suitable community activities they could enjoy and benefit from. Social prescribing has been used since the 1980s in the UK and was formally launched as a national programme by NHS England in 2018. But its usage in CAMHS has only begun to grow in the last few years.
The SPYN social prescribing pathway is one example of social prescribing being implemented within CAMHS at the moment. It is currently being rolled out across selected CAMHS in England. But it is important to ascertain if it has benefits for patients and CAMHS. So, working with up to 10 sites across England who are providing the SPYN social prescribing pathway, the study will:
1. Examine whether the new social prescribing pathway:
i) Impacts on the mental health, wellbeing and social experiences of CYP
ii) Impacts on service-level outcomes
2. Assess factors which influence the implementation of the pathway within CAMHS
Findings from Wellbeing While Waiting will be widely shared via various channels (e.g. journal articles, evidence briefings) to key policy, practice and research stakeholders. The findings could support the work of dozens of CAMHS nationally who are piloting similar schemes or looking to copy the SPYN programme.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
CAMHS • Do not have a SPYN social prescribing pathway due to launch in 2023 CYP participants • CYP with eating disorders, psychosis or severe and complex difficulties (judged by the assessing clinician)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University College London and funded by Wellcome Trust .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 54799
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
